Norris Medicines Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹0.65Cr |
Net Profits | ₹0.27Cr |
Net Profit Margins | -41.54% |
Highlights
Revenue:
Norris Medicines Ltd’s revenue fell -79.5% since last year same period to ₹0.65Cr in the Q3 2023-2024. On a quarterly growth basis, Norris Medicines Ltd has generated -74.61% fall in its revenue since last 3-months.
Net Profits:
Norris Medicines Ltd’s net profit fell -35% since last year same period to ₹0.27Cr in the Q3 2023-2024. On a quarterly growth basis, Norris Medicines Ltd has generated 43.75% jump in its net profits since last 3-months.
Net Profit Margins:
Norris Medicines Ltd’s net profit margin fell -558.38% since last year same period to -41.54% in the Q3 2023-2024. On a quarterly growth basis, Norris Medicines Ltd has generated -121.54% fall in its net profit margins since last 3-months.
